Spain’s competition authority, CNMC, has published a report on the Royal Decree to Regulate the Financing and Price Setting of Medicine and Sanitary Products. The new regulation presented by the Ministry of Health, seeks to regulate two crucial aspects of medication and medical supplies: financing by the National Health Service (SNS) and the prices of each.
Featured News
Prediction Markets Face a Defining Legal Test
Aug 11, 2026 by
CPI
A Court Just Decided Your AI Browser Isn’t a Hacker
Aug 11, 2026 by
CPI
Judge Refuses to Pause NCAA Eligibility Order Amid Antitrust Fight
Aug 11, 2026 by
CPI
US Opens Antitrust Review of Kone’s $34 Billion TK Elevator Acquisition
Aug 11, 2026 by
CPI
Paramount-Warner Deal Turns Into Test of State Antitrust Power
Aug 11, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes